Abstract:Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and ranks third in mortality rate worldwide. Brefeldin A (BFA, 1), a natural Arf1 inhibitor, qualifies extremely superior antitumor activity against HCC while its low aqueous solubility, poor bioavailability, and high toxicity have greatly hindered its translation to the clinic. Herein, a series of BFA-cinnamic acid ester derivatives was rationally designed and synthesized via introducing active cinnamic acid and its analogues into the structure of 1. Their in vitro cytotoxic activities on five cancer cell lines, including HepG2, BEL-7402, HeLa, Eca-109 and PANC-1, were evaluated using MTT assay. As expected, favorable cytotoxic activity was observed on majority of the mono-substituted derivatives. Especially, the most potent brefeldin A 4-O-(4)-dimethylaminocinnamate (CHNQD-01269, 33) with improved aqueous solubility, demonstrated the strong cytotoxic activity against HepG2 and BEL-7402 cell lines with IC50 values of 0.29 and 0.84 μM, respectively. More importantly, 33 performed low toxicity on normal liver cell line L-02 with the selectivity index (SI) of 9.69, which was more than 17-fold higher than that of 1. Results from mechanistic studies represented that 33 blocked the cell cycle in the G1 phase, and induced apoptosis via elevating reactive oxygen species (ROS) production and increasing expression of apoptosis-related proteins of HepG2 cells. Docking experiment also suggested 33 a promising Arf1 inhibitor, which was confirmed by the cellular thermal shift assay that 33 displayed a significant effect on the stability of Arf1 protein. Furthermore, 33 possessed high safety profile (MTD >100 mg/kg, ip) and favorable pharmacokinetic properties. Notably, the superior antiproliferative activity was verified in HepG2 tumor-bearing xenograft model in which 33 markedly suppressed the tumor growth (TGI = 46.17%) in nude mice at a dose of 10 mg/kg once a day for 16 d. The present study provided evidence of exploiting this series of highly efficacious derivatives, especially 33, for the treatment of HCC.

Synthesis and Cytotoxic Evaluation of Acylated Brefeldin A Derivatives As Potential Anticancer Agents

New brefeldin A-cinnamic acid ester derivatives as potential antitumor agents: Design, synthesis and biological evaluation

Semi-Synthesis, Cytotoxic Evaluation, and Structure-Activity Relationships of Brefeldin A Derivatives with Antileukemia Activity.

5-(4-Hydroxyphenyl)-3 H -1,2-dithiole-3-thione derivatives of brefeldin A: Design, synthesis and cytotoxicity in MDA-MB-231 human breast cancer cells

Design, Synthesis, and Anticancer Activity Evaluation of Hybrids of Azoles and Barbituric Acids.

New analogues of brefeldin A from sediment-derived fungus Penicillium sp. DT-F29

Brefeldin A Delivery Nanomicelles in Hepatocellular Carcinoma Therapy: Characterization, Cytotoxic Evaluation in Vitro, and Antitumor Efficiency in Vivo.

Synthesis, Biological Evaluation and Docking Studies of (E)-3-Aryl-2-(3,4,5-trimethoxybenzoyl) Acrylonitrile Derivatives as Anticancer Agents

Synthesis of Flavone Derivatives via N-Amination and Evaluation of Their Anticancer Activities

Synthesis and mechanistic studies of novel spin-labeled combretastatin derivatives as potential antineoplastic agents.

Synthesis and in Vitro Biological Evaluation of Novel Derivatives of Flexicaulin A Condensation with Amino Acid Trifluoroacetate

Design, Synthesis, and Biological Evaluation of Novel 4‐phenoxypyridine Derivatives As Potential Antitumor Agents

Synthesis and Cytotoxicity of Brefeldin A Conjugated Monomethoxy-Poly(Ethylene Glycol)-B-Poly(L-Lactide) Polymeric Micelles

Synthesis and Biological Evaluation of Novel Anthranilamide Derivatives As Anticancer Agents

Design, Synthesis and Biological Evaluation of Nitrogen-Containing Macrocyclic Bisbibenzyl Derivatives As Potent Anticancer Agents by Targeting the Lysosome.

Synthesis and Biological Evaluation of Novel 1-Aryl, 5(Phenoxy-Substituted)aryl-1,4-pentadien-3-one Derivatives

Synthesis and Evaluation of Novel Anticancer Compounds Derived from the Natural Product Brevilin A

Design, Synthesis and Pharmacological Evaluation of New Acyl Sulfonamides As Potent and Selective Bcl-2 Inhibitors.

Synthesis and in vitro and in vivo biological evaluation of novel derivatives of flexicaulin A as antiproliferative agents

Synthesis of N-Substituted Benzamide Derivatives and Their Evaluation As Antitumor Agents

Synthesis and In-Vitro Cytotoxicity of (E)-N,2,3-triarylacrylamide Derivatives As Analogs of Combretastatin A-4